Sound Shore Management Inc. CT Buys 37,132 Shares of GE HealthCare Technologies Inc. $GEHC

Sound Shore Management Inc. CT grew its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.8% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,017,888 shares of the company’s stock after acquiring an additional 37,132 shares during the period. GE HealthCare Technologies comprises approximately 2.7% of Sound Shore Management Inc. CT’s investment portfolio, making the stock its 22nd biggest holding. Sound Shore Management Inc. CT’s holdings in GE HealthCare Technologies were worth $83,487,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of GEHC. Allstate Corp raised its stake in GE HealthCare Technologies by 100.3% in the fourth quarter. Allstate Corp now owns 32,688 shares of the company’s stock worth $2,681,000 after buying an additional 16,365 shares in the last quarter. Temasek Holdings Private Ltd bought a new position in GE HealthCare Technologies in the third quarter worth approximately $99,922,000. Envestnet Asset Management Inc. raised its stake in GE HealthCare Technologies by 15.8% in the third quarter. Envestnet Asset Management Inc. now owns 338,914 shares of the company’s stock worth $25,452,000 after buying an additional 46,231 shares in the last quarter. Sound Shore Management Inc CT raised its stake in GE HealthCare Technologies by 14.6% in the third quarter. Sound Shore Management Inc CT now owns 980,756 shares of the company’s stock worth $73,655,000 after buying an additional 125,062 shares in the last quarter. Finally, Waverton Investment Management Ltd raised its stake in GE HealthCare Technologies by 2.8% in the third quarter. Waverton Investment Management Ltd now owns 1,086,668 shares of the company’s stock worth $81,582,000 after buying an additional 29,897 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $62.03 on Thursday. The business’s fifty day simple moving average is $67.19 and its 200-day simple moving average is $75.63. The company has a market cap of $28.22 billion, a PE ratio of 14.84, a PEG ratio of 1.40 and a beta of 0.74. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The firm had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. During the same period in the previous year, the company earned $1.01 earnings per share. GE HealthCare Technologies’s revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Analysts expect that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

Insider Transactions at GE HealthCare Technologies

In other news, insider Frank R. Jimenez bought 1,750 shares of the business’s stock in a transaction that occurred on Thursday, April 30th. The shares were purchased at an average cost of $60.45 per share, with a total value of $105,787.50. Following the transaction, the insider directly owned 93,932 shares in the company, valued at approximately $5,678,189.40. The trade was a 1.90% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Peter J. Arduini bought 4,169 shares of the business’s stock in a transaction that occurred on Thursday, April 30th. The stock was purchased at an average cost of $59.92 per share, for a total transaction of $249,806.48. Following the completion of the transaction, the chief executive officer owned 259,424 shares in the company, valued at $15,544,686.08. This trade represents a 1.63% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders acquired 21,847 shares of company stock worth $1,361,355 over the last 90 days. Insiders own 0.36% of the company’s stock.

Wall Street Analyst Weigh In

GEHC has been the subject of a number of recent research reports. Stifel Nicolaus set a $80.00 price objective on shares of GE HealthCare Technologies in a research note on Wednesday, April 29th. Argus reduced their price target on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a research report on Tuesday, May 19th. BTIG Research reduced their price target on GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Barclays reduced their price target on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 30th. Finally, UBS Group raised GE HealthCare Technologies from a “sell” rating to a “neutral” rating and reduced their price target for the stock from $75.00 to $69.00 in a research report on Thursday, May 21st. Nine equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $80.21.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.